Literature DB >> 8001937

Expanded gold standard in the diagnosis of Chlamydia trachomatis in a low prevalence population: diagnostic efficacy of tissue culture, direct immunofluorescence, enzyme immunoassay, PCR and serology.

H Thejls1, J Gnarpe, H Gnarpe, P G Larsson, J J Platz-Christensen, L Ostergaard, A Victor.   

Abstract

OBJECTIVE: To evaluate the diagnostic efficacy of chlamydia culture, direct immunofluorescence (DFA), direct enzyme immunoassay (EIA), polymerase chain reaction (PCR) and serology by defining positive culture or at least two positive non-culture tests as true positive.
SETTING: Three gynaecological departments located in separate areas of Sweden. PATIENTS AND
DESIGN: All pregnant women requesting abortion during a six month period were included. In cases with unconfirmed non-culture tests, reculture with multiple passage and PCR on the culture transport medium was performed for confirmation. Serum was analysed for chlamydial antibodies type IgG, IgM and IgA using microimmunofluorescence.
RESULTS: 18 of 419 (4.3%) patients were positive for chlamydia according to the defined criteria. Twelve of 419 (2.9%) were positive in standard culture (primary inoculation). The sensitivity of standard culture, DFA, EIA and PCR were 66.7%, 77.8%, 64.7% and 71.4% respectively. The specificity 100% (by definition), 99.5%, 100%, 100% respectively. The positive predictive value 100% (by definition), 87.5%, 100%, 100% respectively. Negative predictive value 98.5%, 99.0%, 98.5%, 98.9% respectively. Serum IgG titre of > or = 64 and > or = 1024 gave positive predictive values of 10% and 21% respectively.
CONCLUSIONS: When an expanded gold standard is used, the specificity and positive predictive value of the non-culture tests used are comparable with that of standard culture even in this low prevalence population. Standard culture underestimated the chlamydia prevalence by 33%. The prevalence found represents a decrease from 10 to 2.9% of culture verified chlamydia during four years in comparable populations. Chlamydial antibodies of certain immunological classes are not necessarily present in cases with chlamydia.

Entities:  

Mesh:

Year:  1994        PMID: 8001937      PMCID: PMC1195269          DOI: 10.1136/sti.70.5.300

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  16 in total

Review 1.  Clinical and laboratory considerations of culture vs antigen assays for detection of Chlamydia trachomatis from genital specimens.

Authors:  J A Kellogg
Journal:  Arch Pathol Lab Med       Date:  1989-05       Impact factor: 5.534

2.  Chlamydia trachomatis in the fallopian tubes of women without laparoscopic evidence of salpingitis.

Authors:  C Stacey; P Munday; B Thomas; C Gilchrist; D Taylor-Robinson; R Beard
Journal:  Lancet       Date:  1990-10-20       Impact factor: 79.321

3.  A 2-year quantitative assessment of Chlamydia trachomatis in a sexually transmitted diseases clinic population by the MicroTrak direct smear immunofluorescence test.

Authors:  B J Thomas; M F Osborn; P E Munday; R T Evans; D Taylor-Robinson
Journal:  Int J STD AIDS       Date:  1990-07       Impact factor: 1.359

4.  Accuracy of Chlamydia trachomatis antigen detection methods in a low-prevalence population in a primary care setting.

Authors:  P H Gann; J E Herrmann; L Candib; R W Hudson
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

5.  General colorimetric method for DNA diagnostics allowing direct solid-phase genomic sequencing of the positive samples.

Authors:  J Wahlberg; J Lundeberg; T Hultman; M Uhlén
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 6.  Chlamydial infections in pediatrics: diagnostic and therapeutic considerations.

Authors:  P J Rettig
Journal:  Pediatr Infect Dis       Date:  1986 Jan-Feb

7.  Molecular cloning and sequence analysis of a developmentally regulated cysteine-rich outer membrane protein from Chlamydia trachomatis.

Authors:  I N Clarke; M E Ward; P R Lambden
Journal:  Gene       Date:  1988-11-30       Impact factor: 3.688

8.  Modification of the microimmunofluorescence test to provide a routine serodiagnostic test for chlamydial infection.

Authors:  J D Treharne; S Darougar; B R Jones
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

9.  Effects of broadening the gold standard on the performance of a chemiluminometric immunoassay to detect Chlamydia trachomatis antigens in centrifuged first void urine and urethral swab samples from men.

Authors:  D Jang; J W Sellors; J B Mahony; L Pickard; M A Chernesky
Journal:  Sex Transm Dis       Date:  1992 Nov-Dec       Impact factor: 2.830

Review 10.  Laboratory diagnosis of human chlamydial infections.

Authors:  R C Barnes
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

View more
  17 in total

1.  Chlamydia trachomatis diagnostics.

Authors:  M A Chernesky
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

2.  Evaluation of the microparticle enzyme immunoassay Abbott IMx Select Chlamydia and the importance of urethral site sampling to detect Chlamydia trachomatis in women.

Authors:  M K Brokenshire; P J Say; A H van Vonno; C Wong
Journal:  Genitourin Med       Date:  1997-12

3.  Epidemiology and transmission patterns of concomitant genital chlamydial and gonococcal infections.

Authors:  P Matondo; I Johnson; S Sivapalan
Journal:  Genitourin Med       Date:  1995-08

4.  Under-diagnosis of female genital Chlamydia trachomatis infection.

Authors:  C Y Tong; I A Tait
Journal:  Genitourin Med       Date:  1996-04

5.  Comparison of an automated enzyme immunoassay with a direct fluorescent antibody test and polymerase chain reaction for the detection of Chlamydia trachomatis in diagnostic specimens from male patients.

Authors:  C Y Tong; C Valentine; O P Arya
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

6.  "Does ligase chain reaction assay of urine in the diagnosis of Chlamydia trachomatis offer significant improvement over existing diagnostic tests?"--a critical appraisal of the evidence.

Authors:  L Grun; J Sheldon
Journal:  Genitourin Med       Date:  1996-12

7.  Lowering the cut off value of an automated chlamydia enzyme immunoassay and confirmation by PCR and direct immunofluorescent antibody test.

Authors:  C Y Tong; C Donnelly; N Hood
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

8.  Detection of Chlamydia trachomatis infections in women by Amplicor PCR: comparison of diagnostic performance with urine and cervical specimens.

Authors:  R Pasternack; P Vuorinen; A Kuukankorpi; T Pitkäjärvi; A Miettinen
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

9.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

10.  Use of PCR and direct immunofluorescence microscopy for confirmation of results obtained by Syva MicroTrak Chlamydia enzyme immunoassay.

Authors:  L Ostergaard; J K Møller
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.